v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 37,739 $ 21,361 $ 66,168 $ 40,066
General and administrative 11,875 16,289 23,821 27,469
Total operating expenses 49,614 37,650 89,989 67,535
Interest income, net (1,154) 0 (1,154) 0
Other (income) expense (793) 84 (1,147) 711
Loss before provision (benefit) for income taxes (47,667) (37,734) (87,688) (68,246)
Provision (benefit) for income taxes 261 (31) 613 (72)
Net loss $ (47,928) $ (37,703) $ (88,301) $ (68,174)
Net loss per common share - basic (in dollars per share) $ (0.41) $ (0.35) $ (0.76) $ (0.66)
Net loss per common share - diluted (in dollars per share) $ (0.41) $ (0.35) $ (0.76) $ (0.66)
Weighted-average common shares outstanding – basic (in shares) 116,572,820 109,078,427 116,630,076 103,558,036
Weighted-average common shares outstanding – diluted (in shares) 116,572,820 109,078,427 116,630,076 103,558,036

Source